The videos did not follow the FDAs advice from May 3, 2024, in which it recommended including disclosure about gastrointestinal adverse reactions associated with Zepbound
It is possible that the therapy under investigation, GLP-1 receptor agonists, is not responsible for the observed increased incidence of kidney cancer
These biomarkers identify contraindications and guide starting dose, titration pace, and monitoring intervals throughout treatment
Yes, they can often be combined with DMARDs, biologics, and other diabetes drugsalways under close provider supervision. Are GLP-1 medications effective in conditions like rheumatoid arthritis, psoriatic arthritis, lupus, and osteoarthritis
What to Know Before You Try It Youve probably seen it on TikTok or Instagram: people cutting their Ozempic dose in half, stretching their Zepbound supply an extra week or two, or buying compounded doses of GLP-1s from telehealth platforms
Final practical notes from our clinical experience We believe in empowering patients through education and careful stewardship of emerging tools
.png)
